SHOCKWAVE MEDICAL INC (SWAV) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SWAV • US82489T1043

334.75 USD
-0.08 (-0.02%)
At close: May 30, 2024
334.8 USD
+0.05 (+0.01%)
After Hours: 5/30/2024, 8:19:22 PM
Fundamental Rating

6

SWAV gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. SWAV is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SWAV is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, SWAV could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year SWAV was profitable.
  • In the past year SWAV had a positive cash flow from operations.
  • In multiple years SWAV reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: SWAV reported negative operating cash flow in multiple years.
SWAV Yearly Net Income VS EBIT VS OCF VS FCFSWAV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M 200M

1.2 Ratios

  • SWAV has a Return On Assets of 9.95%. This is amongst the best in the industry. SWAV outperforms 93.23% of its industry peers.
  • The Return On Equity of SWAV (21.76%) is better than 95.31% of its industry peers.
  • SWAV's Return On Invested Capital of 8.81% is amongst the best of the industry. SWAV outperforms 88.54% of its industry peers.
Industry RankSector Rank
ROA 9.95%
ROE 21.76%
ROIC 8.81%
ROA(3y)13.4%
ROA(5y)-1.2%
ROE(3y)20.17%
ROE(5y)0.98%
ROIC(3y)N/A
ROIC(5y)N/A
SWAV Yearly ROA, ROE, ROICSWAV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -50 -100

1.3 Margins

  • With an excellent Profit Margin value of 20.76%, SWAV belongs to the best of the industry, outperforming 94.79% of the companies in the same industry.
  • The Operating Margin of SWAV (20.52%) is better than 94.27% of its industry peers.
  • SWAV has a better Gross Margin (86.99%) than 96.35% of its industry peers.
  • SWAV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20.52%
PM (TTM) 20.76%
GM 86.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.99%
GM growth 5Y16.42%
SWAV Yearly Profit, Operating, Gross MarginsSWAV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SWAV is destroying value.
  • The number of shares outstanding for SWAV has been increased compared to 1 year ago.
  • The debt/assets ratio for SWAV is higher compared to a year ago.
SWAV Yearly Shares OutstandingSWAV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
SWAV Yearly Total Debt VS Total AssetsSWAV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 10.26 indicates that SWAV is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 10.26, SWAV belongs to the top of the industry, outperforming 86.98% of the companies in the same industry.
  • The Debt to FCF ratio of SWAV is 4.41, which is a neutral value as it means it would take SWAV, 4.41 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of SWAV (4.41) is better than 82.81% of its industry peers.
  • SWAV has a Debt/Equity ratio of 0.97. This is a neutral value indicating SWAV is somewhat dependend on debt financing.
  • The Debt to Equity ratio of SWAV (0.97) is worse than 76.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 4.41
Altman-Z 10.26
ROIC/WACC0.94
WACC9.36%
SWAV Yearly LT Debt VS Equity VS FCFSWAV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

  • SWAV has a Current Ratio of 13.81. This indicates that SWAV is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of SWAV (13.81) is better than 97.92% of its industry peers.
  • A Quick Ratio of 12.61 indicates that SWAV has no problem at all paying its short term obligations.
  • SWAV has a Quick ratio of 12.61. This is amongst the best in the industry. SWAV outperforms 97.40% of its industry peers.
Industry RankSector Rank
Current Ratio 13.81
Quick Ratio 12.61
SWAV Yearly Current Assets VS Current LiabilitesSWAV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

  • SWAV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.34%, which is quite good.
  • SWAV shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.44%.
  • The Revenue has been growing by 126.31% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)12.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.81%
Revenue 1Y (TTM)41.44%
Revenue growth 3Y120.84%
Revenue growth 5Y126.31%
Sales Q2Q%35.85%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.56% on average over the next years. This is quite good.
  • SWAV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.10% yearly.
EPS Next Y36.11%
EPS Next 2Y27.65%
EPS Next 3Y24.15%
EPS Next 5Y17.56%
Revenue Next Year27.69%
Revenue Next 2Y24.82%
Revenue Next 3Y23.61%
Revenue Next 5Y20.1%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SWAV Yearly Revenue VS EstimatesSWAV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
SWAV Yearly EPS VS EstimatesSWAV Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 78.21, SWAV can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, SWAV is valued a bit cheaper than 67.19% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SWAV to the average of the S&P500 Index (28.39), we can say SWAV is valued expensively.
  • The Price/Forward Earnings ratio is 53.09, which means the current valuation is very expensive for SWAV.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SWAV indicates a somewhat cheap valuation: SWAV is cheaper than 68.75% of the companies listed in the same industry.
  • SWAV is valuated expensively when we compare the Price/Forward Earnings ratio to 25.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 78.21
Fwd PE 53.09
SWAV Price Earnings VS Forward Price EarningsSWAV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • SWAV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SWAV is cheaper than 67.19% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, SWAV is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 75.65
EV/EBITDA 66.43
SWAV Per share dataSWAV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of SWAV may justify a higher PE ratio.
  • SWAV's earnings are expected to grow with 24.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.17
PEG (5Y)N/A
EPS Next 2Y27.65%
EPS Next 3Y24.15%

0

5. Dividend

5.1 Amount

  • No dividends for SWAV!.
Industry RankSector Rank
Dividend Yield N/A

SHOCKWAVE MEDICAL INC / SWAV FAQ

What is the fundamental rating for SWAV stock?

ChartMill assigns a fundamental rating of 6 / 10 to SWAV.


What is the valuation status for SWAV stock?

ChartMill assigns a valuation rating of 4 / 10 to SHOCKWAVE MEDICAL INC (SWAV). This can be considered as Fairly Valued.


What is the profitability of SWAV stock?

SHOCKWAVE MEDICAL INC (SWAV) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for SWAV stock?

The Earnings per Share (EPS) of SHOCKWAVE MEDICAL INC (SWAV) is expected to grow by 36.11% in the next year.